OpenAlex
PricingAboutJobs
Log inGet started
Work

ABT-414, an Antibody–Drug Conjugate Targeting a Tumor-Selective EGFR Epitope

HTML

Year: 2016
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-15-0901
Authors: Andrew C. Phillips, Erwin R. Boghaert, Kedar S. Vaidya, Michael J. Mitten, Suzanne Norvell, Hugh D. Falls, Peter J. DeVries, Dong Cheng, Jonathan A. Meulbroek, Fritz G. Buchanan, Laura M. McKay, Neal C. Goodwin, Edward B. Reilly
Institutions: AbbVie (United States), Jackson Laboratory
Language: English

Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: ABT-414, antibody-drug conjugates, EGFR, monomethyl auristatin F, EGFRvIII, glioblastoma, tumor-specific epitopes, EGFR mutation, xenograft models, targeted cancer therapy
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2290428590
FWCI: 10.77
Cites: 47
Cited by: 194
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms